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Abstract
Cullin-RING ubiquitin ligases (CRLs) comprise the largest known category of ubiquitin ligases.
CRLs regulate an extensive number of dynamic cellular processes, including multiple aspects of the
cell cycle, transcription, signal transduction, and development. CRLs are multisubunit complexes
composed of a cullin, RING H2 finger protein, a variable substrate-recognition subunit (SRS), and
for most CRLs, an adaptor that links the SRS to the complex. Eukaryotic species contain multiple
cullins, with five major types in metazoa. Each cullin forms a distinct class of CRL complex, with
distinct adaptors and/or substrate-recognition subunits. Despite this diversity, each of the classes
of CRL complexes is subject to similar regulatory mechanisms. This review focuses on the global
regulation of CRL complexes, encompassing: neddylation, deneddylation by the COP9 Signalosome
(CSN), inhibitory binding by CAND1, and the dimerization of CRL complexes. We also address
the role of cycles of activation and inactivation in regulating CRL activity and switching between
substrate-recognition subunits.
Introduction
Protein degradation is critical for the regulation of a large
number of diverse cellular processes. The majority of pro-
tein degradation in cells occurs via the ubiquitin-medi-
ated proteolytic pathway [1,2]. Ubiquitin is an
evolutionarily conserved 76 amino acid polypeptide that
is covalently attached to target proteins by the concerted
actions of three classes of enzymes [3,4]. A ubiquitin-acti-
vating enzyme (E1) utilizes one ATP to bind ubiquitin via
a thiolester linkage. The activated ubiquitin is then trans-
ferred to a ubiquitin-conjugating enzyme (E2). E2s inter-
act with ubiquitin-protein ligases (E3s), which also bind
the substrate. The E3 brings the E2 and the substrate
together. The E2 can then either directly conjugate ubiqui-
tin to the substrate or, in the case of HECT-domain E3s,
transfer the ubiquitin as a high-energy thiol intermediate
to the E3, which then transfers it to the substrate. The
attachment of a single ubiquitin to a substrate can alter
protein function or localization [5]. The tandem attach-
ment of multiple ubiquitin to form a polyubiquitin chain
can also alter function or localization, or mark the sub-
strate for degradation by the 26S proteasome, depending
on the type of linkage within the polyubiquitin chain [6].
Ubiquitin ligases provide the substrate specificity for
ubiquitination (ubiquitylation) reactions. The largest
known class of ubiquitin ligases are cullin-RING ubiqui-
tin ligases (CRLs) [7]. CRLs regulate diverse cellular proc-
esses, including multiple aspects of the cell cycle,
transcription, signal transduction, and development [7].
CRLs are multisubunit complexes that include a cullin, a
RING H2 finger protein, a substrate-recognition subunit
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(SRS), and with the exception of CUL3-based CRLs, an
adaptor subunit that links the SRS to the complex. There
are five major categories of cullins in metazoa (CUL1
through CUL5) [8,9], and an additional, potentially verte-
brate-specific class containing CUL7 and PARC (Parkin-
like cytoplasmic protein) [10]. CRLs are activated by the
covalent attachment of the ubiquitin-like protein Nedd8
to the cullin, and are inhibited by binding to the CAND1
inhibitor [7]. Recently, it has become apparent that many
CRLs function as dimers, which is another potential
source of regulation. This review describes the global reg-
ulatory mechanisms that govern CRL activity, and high-
lights the current gaps in our understanding.
The structure of CRL complexes
The most intensively studied cullin is metazoan CUL1
and its budding yeast ortholog Cdc53. CUL1 and Cdc53-
based CRLs are called SCF complexes, and contain four
subunits: Skp1; CUL1 (Cdc53); an F-box protein; and the
RING H2 finger protein Rbx1/Roc1/Hrt1 [7]. The crystal
structure of the SCF complex reveals that the cullin acts as
a rigid backbone for the assembly of the complex [11,12]
(Fig. 1A). The CUL1 C-terminus binds Rbx1 and the N-ter-
minus binds the adaptor Skp1. Rbx1 facilitates the recruit-
ment of the E2 to the complex [13]. The adaptor Skp1
binds the SRS, which is an F-box protein that links to Skp1
through the F-box motif. The F-box protein binds and
positions the substrate for ubiquitination by the E2. The
combination of distinct F-box proteins with the core com-
ponents creates unique SCF complexes that bind distinct
sets of substrates. Metazoan genomes contain a relatively
large number of genes encoding F-box proteins, e.g.,
humans have ~70 F-box proteins, while C. elegans has
over 300 [14,15]. Many uncharacterized yeast and mam-
malian F-box proteins are capable of forming SCF com-
plexes in vitro, suggesting the existence of a large number
of SCF complexes [16,17]. F-box proteins generally bind
to phosphorylated residues on substrates, and therefore,
substrate degradation by SCF complexes is regulated by
phosphorylation [7].
CUL2-based CRL complexes have a structure similar to
that of the SCF complex (Fig. 1B). Rbx1 similarly binds to
the C-terminus of CUL2, and the adaptor Elongin C binds
to the N-terminus [18,19]. Elongin C is a Skp1-related
protein that binds the complex as a heterodimer with the
ubiquitin-related protein Elongin B [20]. SRSs bind to
Elongin C through a VHL-box protein motif in the SRS
[21].
CUL5 is the closest paralog to CUL2 [9], and CUL5 CRLs
have a structure similar to that of CUL2 CRLs [21,22] (Fig.
1C). Both CUL-2 and CUL-5 CRLs employ Elongin C as
the adaptor protein. Despite containing the same adaptor
protein, CUL2 and CUL5 complexes bind different classes
of SRSs. CUL5 complex SRSs utilize the SOCS-box motif
to bind to Elongin C. The SOCS-box motif is similar to the
VHL-box motif of CUL2 complex SRSs. Both motifs have
an N-terminal subdomain (the BC-box) that binds
Elongin C. However, the C-terminal regions of the motifs
are distinct: the SOCS-box has a CUL5-box subdomain;
and the VHL-box has a CUL2-box subdomain. These C-
terminal subdomains are proposed to bind to the relevant
cullin and thereby provide specificity [21,23]. CUL5 CRL
complexes also utilize the RING H2 finger protein Rbx2/
Roc2 rather than the related Rbx1, which is present in the
other classes of CRLs [24].
CUL3 CRL complexes contain Rbx1, but differ from other
CRL classes in that there is no adaptor protein (Fig. 1D).
Instead, the SRS binds directly to the N-terminus of CUL3
using a BTB/POZ domain [25-28]. There are hundreds of
BTB proteins in metazoan species, suggesting large num-
bers of distinct CUL3 complexes [7].
CUL4 CRL complexes contain Rbx1 and the adaptor pro-
tein DDB1 [29,30] (Fig. 1E). DDB1 binds to SRSs that
contain WD-repeats of a subclass called 'WDXR' or 'DXR',
which mediate interaction with DDB1 [31-34]. In at least
one case, DDB1 has been reported to bind a substrate
directly, providing the possibility that DDB1 can function
as both an adaptor and an SRS [35].
Structures of multisubunit CRL complexes Figure 1
Structures of multisubunit CRL complexes. Diagrams 
of the CUL1 (A), CUL2 (B), CUL5 (C), CUL3 (D), and CUL4 
(E) CRL complexes. Proteins in the complexes are labeled. 
The structures are described in the text.
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The nomenclature for CRLs is only well established for
CUL1-based SCF complexes. The naming of other CRL
complexes is not settled, with various competing acro-
nyms. For this review, we will refer to non-SCF CRL com-
plexes by using the acronym "CRL" for cullin RING
ubiquitin ligase followed by the number of the cullin, and
a superscript to denote the SRS. Therefore, a CUL3 CRL
complex with the SRS Keap1 will be referred to as
CRL3Keap1.
Dimerization of CRLs
Recently it has become apparent that a number of CRL
complexes function as dimers. CUL1, CUL3 and CUL4-
based CRL complexes have been observed to form dimers
or multimers in vivo [36-38]. In contrast, CUL2 and CUL5
CRL complexes have only been observed as monomers
[36]. There are two potential mechanisms of dimeriza-
tion: SRS-mediated dimerization (which has been dem-
onstrated for SCF complexes); and a Nedd8-cullin linkage
(which has been demonstrated for CUL3 CRL complexes).
SRS-mediated dimerization relies on binding between
SRS proteins to link together two CRL complexes. Multi-
ple F-box proteins have been observed to form dimers in
vivo, including Fbw7, Pop1 & Pop2, Cdc4, Met30, Skp2,
and βTrcp1 & βTrcp2 [39-45]. Dimerization of F-box pro-
teins is initiated through a conserved D-domain located
immediately N-terminal of the F-box motif [38,42,44].
Analysis of SCFCdc4 complexes by small angle X-ray scatter
analysis indicates that the two substrate-binding sites of
the SRSs and the two E2-binding sites form a coplanar sur-
face in a suprafacial orientation [38] (Fig. 2A).
The bivalent geometry of the dimeric SCF structure pro-
vides different distances between a substrate-binding site
and the two E2 docking sites [38] (Fig. 3B). These distinct
catalytic site-to-substrate distances can allow an SCF com-
plex to target different-sized substrates and accommodate
changes in the length of the elongating polyubiquitin
chain [38] (Fig. 3). For the SCFCdc4 complex, dimerization
does not affect its affinity for the substrate Sic1, but is
required for optimal ubiquitin chain initiation and elon-
gation [38,44]. The in vitro ubiquitination of three of four
tested SCFCdc4 substrates is more efficiently ubiquitinated
by dimeric SCFCdc4 [38]. Similarly, dimeric mammalian
SCFFbw7/hCdc4 can more efficiently ubiquitinate its sub-
strate cyclin E than can monomeric SCFFbw7/hCdc4 [44].
Dimerization also provides the potential for the two SRSs
in the complex to work together to bind one substrate so
that it is optimally tethered for ubiquitination, as has
been proposed for the dimeric CRL3Keap1 complex binding
to its substrate Nrf2 [46].
SRSs can bind to SCF complexes as both homodimers and
heterodimers. The F-box proteins βTrCP1 and βTrCP2
form both homo and heterodimeric complexes, but only
Proposed models for dimerization of CRL complexes Figure 2
Proposed models for dimerization of CRL com-
plexes. (A) Diagram of an SRS-mediated dimeric SCF com-
plex. Dimerization is mediated by interactions between the 
SRSs in each CRL. This structure has been experimentally 
confirmed [38]. (B) Diagram of a Nedd8-cullin-based dimeric 
CRL3 complex. Dimerization is mediated by interaction 
between Nedd8, which is covalently linked to one CUL3 
protein, and the WH-B domain of an unneddylated CUL3 
[37]. The overall structure of the Nedd8-cullin-based dimer 
has not been determined. The dimer is drawn in a head-to-
head conformation to accommodate the binding of a dimeric 
SRS to the two CUL3 N-termini (as many CRL3 SRSs are 
constitutively dimeric in vivo). (C) Diagram of a monomeric 
CRL2 complex binding a dimeric SRS. The existence of such 
a structure has not yet been directly confirmed by experi-
ments (see text). Proteins are labeled as in Fig. 1.
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the homodimeric forms of each can ubiquitinate the sub-
strate Iκ Bα [39]. In contrast, the fission yeast F-box pro-
teins Pop1 and Pop2 target the degradation of the
substrates Cdc18p and Rum1p as a heterodimeric Pop1/
Pop2 complex even though both Pop1 and Pop2 can also
form homodimers [41,42]. Thus both homodimers and
heterodimers can form active SCF complexes, thereby pro-
viding the possibility for combinatorial regulation of SCF
activity.
Many CUL3 complex SRSs form homodimers, including
Keap1, MEL-26, RhoBTB2, and SPOP [27,46-48]. Never-
theless, the dimerization mechanism that has been
reported for CUL3 complexes does not require SRS dimer-
ization, but rather involves physical interaction between
an unneddylated CUL3 and a Nedd8 that is covalently
bound to another CUL3 [37] (Fig. 2B). The winged-helix
B (WH-B) domain in the C-terminus of the unneddylated
CUL3 binds to Nedd8. As Nedd8 is conjugated to a lysine
residue within the WH-B domain, the same region of both
CUL3 proteins is involved in the interaction.
There is, however, conflicting data on the prevalence of
Nedd8-cullin-based dimerization. While Wimuttisuk and
Singer found that CUL3 with a mutated SRS-binding site
still forms dimers in vivo (thereby providing evidence for
Nedd8-cullin-based interaction) [37], Chew et al. found
that CUL3 with a mutated SRS-binding site does not form
dimers in vivo [36]. Both groups used the same experimen-
tal strategy and cell line. The divergent results imply either
that Nedd8-cullin-based interaction is the dominant
method of dimerization, or that it has at most a minor
role in CUL3 dimerization (and that SRS-based dimeriza-
tion is predominant). Thus the importance of the Nedd8-
cullin binding mechanism is currently unresolved.
Do other cullins besides CUL3 form Nedd8-cullin dim-
ers? It has been observed that human CUL1 in which the
adaptor-binding region has been mutated can still form
dimers or multimers in vivo, suggesting an SRS-independ-
ent interaction mechanism [36]. In contrast, the dimeriza-
tion of budding yeast SCFCdc4 occurs exclusively through
an SRS-mediated mechanism [38]. Moreover, in budding
yeast, Nedd8-cullin interaction is unlikely to be an impor-
tant dimerization pathway, as the Nedd8 ortholog Rub1 is
not required for viability, and so cannot be essential for
cullin functions [49,50]. It should be noted that budding
yeast do not have a clear CUL3 ortholog [9], and it is pos-
sible that Nedd8-cullin dimerization is specific for CUL3.
One of the characteristics of the Nedd8-cullin dimeriza-
tion mechanism is that the dimeric CRL complex must
have equal levels of neddylated and unneddylated cullins.
Immunoprecipitation of the CUL3 substrate cyclin E pulls
down roughly equivalent levels of neddylated and unned-
dylated CUL3 [37]. In contrast, immunoprecipitation of
the substrates of CRL2VHL or SCFβTrCP pulls down predom-
inantly neddylated cullins, implying that SCFβTrCP and
CRL2VHL  do not function as Nedd8-cullin dimers
[13,51,52]. These results suggest that Nedd8-cullin dimer-
ization is not widespread among other (non-CRL3)
classes of CRL complexes.
It has been reported that the CRL2 SRS VHL (von Hippel-
Lindau tumor suppressor protein) is a dimer in vivo and
that the dimerization is required for CRL2VHL activity in
vivo [53]. However, it has also been reported that CUL2 is
not present as a dimer or multimer in cells [36]. A model
Poly-ubiquitination reactions by monomeric and dimeric SCF  complexes Figure 3
Poly-ubiquitination reactions by monomeric and 
dimeric SCF complexes. Diagram of poly-ubiquitin conju-
gation to a substrate (rectangle) by monomeric (A) and 
dimeric (B) SCF complexes. Top panels, E2 with activated 
ubiquitin prior to binding. Middle panels, E2 with activated 
ubiquitin loaded onto E3 but prior to transfer of ubiquitin to 
substrate. Bottom panels, the substrate has a three-ubiquitin 
chain and a new E2 with activated ubiquitin has docked. Note 
how the ability of E2s to load onto both sites of the dimeric 
SCF complex facilitates the addition of ubiquitin onto the 
growing polyubiquitin chain. In the diagram, the addition of 
the first ubiquitin is more sterically favorable from the E2 
docking site that is closer to the substrate, while additions to 
the elongated polyubiquitin chain are more favorable from 
the more distant E2 docking site. Proteins are labeled as in 
Fig. 1.
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that incorporates both of these results is that a monomeric
CRL2 complex binds to dimeric VHL (Fig. 2C). There are
currently no published experiments that directly test this
model.
The turnover of substrate-recognition subunits
SRSs recognize and recruit substrates to the CRL complex.
Genetic evidence from yeast suggests that F-box proteins
compete with each other for binding to the core CRL com-
plex [54,55]. Therefore the regulation of SRS levels
(through synthesis or turnover) can directly influence the
relative proportion of different CRL complexes.
In both yeast and mammals, F-box proteins are often
unstable and undergo proteasome-mediated degradation
as a result of autoubiquitination when linked to the SCF
complex [55-60]. The overexpression of substrates can sta-
bilize F-box proteins because the bound substrate protects
the F-box protein from autoubiquitination [56,60]. Aut-
oubiquitination of SRSs is potentially a broadly based
mechanism among CRLs, as it is also observed for the
CUL3 complex SRSs RhoBTB2 and Keap1 in mammals,
and Btb3 in fission yeast [26,48,61].
In contrast to SCF SRSs, which are often destabilized after
binding the SCF complex, the CUL2 complex SRS VHL is
stabilized by its association with the CRL2 complex
[62,63]. In the absence of binding the CRL2 complex,
VHL is degraded through a proteasome-dependent mech-
anism, presumably via the activity of another E3 [63].
Many other SRS proteins are also degraded through the
activity of other E3s. For example, the APC/C (anaphase
promoting complex/cyclosome) ubiquitin ligase targets
the degradation of the SCF SRSs Skp2 and Tome1, and
SCFβTrCP targets the degradation of the SCF SRS Emi1 [64-
68].
As we shall see in the following sections, a central role of
two major CRL regulators (CSN and CAND1) is to regu-
late the autoubiquitination of SRSs. Uncontrolled autou-
biquitination leads to the inactivation of CRLs due to a
loss of SRSs. On the other hand, SRS turnover is essential
to allow the switching of SRSs among core CRL complexes
so that the relative proportions of different CRLs reflect
changes in SRS levels.
Regulation of CRLs by Nedd8 conjugation
Cullins are post-translationally modified by the covalent
attachment of the ubiquitin-like protein Nedd8 to a con-
served lysine residue in a process termed neddylation
[69]. Nedd8 conjugation increases CRL ubiquitin ligase
activity in vitro [52,70-72] by promoting the recruitment
of the E2 through direct interaction between Nedd8 and
the E2 [13,73]. Based on the interaction of E2s with RING
finger domains (such as is found in Rbx1) [74], it has been
proposed that both Nedd8 and Rbx1 form a common
interface for loading the E2 [73]. Nedd8 conjugation is
required for the in vivo function of CUL1, CUL2, and
CUL3 in a number of metazoan species and fission yeast
[75-78]. However, in budding yeast, Nedd8 is not essen-
tial for SCF-mediated processes, although it does enhance
SCF activity [49,50].
The neddylation reaction is similar to the ubiquitination
reaction, and involves a heterodimeric E1 (APP-BP-1/
Uba3) that activates Nedd8, the E2 UBC12 that conju-
gates Nedd8 to the cullin, and DCN1 (defective in cullin
neddylation) and Rbx1 as E3s [50,51,79-84]. DCN1 was
identified as a protein that promotes the neddylation of
CUL-3 in C. elegans and Cdc53 in budding yeast [80].
DCN1 binds to the cullin and the neddylation E2 UBC12
to facilitate UBC12 loading onto the cullin [81]. While
DCN1 promotes neddylation, it is not essential for the
neddylation reaction in vivo [80]. The CRL component
Rbx1 also plays a central role in neddylation. In vivo, only
cullins that are complexed with Rbx1 undergo neddyla-
tion [51,82-84], and mutation of the RING finger motif of
Rbx1 abolishes neddylation in vitro [82]. Rbx1 can pro-
mote neddylation in vitro in the absence of DCN1 if there
are sufficiently high levels of E2, while the presence of
DCN1 allows neddylation at lower E2 levels [81]. Based
on the observation that DCN1 can physically bind to
Rbx1 [85], it is likely that the two proteins form a multi-
subunit E3 for the neddylation reaction, although it is
possible that Rbx1 is the predominant E3 and DCN1 is a
cofactor.
In C. elegans, loss of DCN-1 causes embryonic arrest due
to loss of CUL-3 activity; while in budding yeast, a DCN1
null mutant is viable, consistent with the observation that
Rub1 (Nedd8) is not essential in budding yeast [80]. A
loss-of-function mutant of an Arabidopsis Dcn1 homolog
had no effect on SCFTIR1-regulated pathways, however,
there may be redundancy as there are three Dcn1-related
genes in Arabidopsis [86]. The mammalian DCN1 ortholog
(SCCRO, squamous cell carcinoma-related oncogene) is
amplified in several human tumors, and functions as an
oncogene when overexpressed [87], however there are
currently no reports on its role in regulating neddylation.
Regulation of CRLs by the CSN complex
The COP9 Signalosome (CSN) is a conserved eight-subu-
nit complex that was originally identified in Arabidopsis
[88,89]. The eight subunits of the CSN complex are
homologous to eight subunits of the 19S proteasome lid
complex and to three subunits of the eIF3 translation ini-
tiation factor complex, suggesting a common origin for
these three protein complexes [90]. CSN physically asso-
ciates with the 26S proteasome, and may function as an
alternate lid for the proteasome [91,92]. CSN has beenCell Division 2008, 3:7 http://www.celldiv.com/content/3/1/7
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implicated in wide range of biological processes including
plant photomorphogenesis, yeast mating pathways, sig-
nal transduction, the regulation of DNA repair, and cell
cycle regulation [93,94]. Biochemically CSN is associated
with three activities, phosphorylation, deneddylation,
and deubiquitination, with the latter two activities
directly regulating CRLs [93,94].
Nedd8 conjugates are removed from cullins (in a process
termed deneddylation) by the isopeptidase activity of the
metalloprotease CSN5/Jab1 subunit of CSN [95,96]. Inac-
tivation of CSN increases the levels of neddylated cullins
in vivo [78,95,97,98]. Counterintuitively, CSN inactiva-
tion reduces the activity of CUL1, CUL3, and CUL4-based
CRL complexes in cells despite increased neddylation lev-
els [29,78,96,97,99-103]. The loss of CRL activity can be
attributed to significantly lower SRS levels due to
increased autoubiquitination of SRSs (as shown in yeast,
humans, Drosophila, and Neurospora) [36,103-107]. The
deneddylation activity of CSN is primarily responsible for
preventing the autoubiquitination of SRSs [107].
The deubiquitinase activity of CSN contributes to the sta-
bilization of CUL1 and CUL3 SRSs in fission yeast, pre-
sumably by removing ubiquitin that is conjugated to the
SRSs [103,104]. CSN deubiquitinase activity also stabi-
lizes Rbx1 in humans [108,109]. In addition to stabilizing
SRSs and Rbx1, CSN is also required for the stability of the
cullins CUL1 and CUL3 in Drosophila, and CUL1 in Neu-
rospora [105,106]. In humans, inactivation of CSN does
not affect cullin levels, except for a modest reduction in
CUL2 [107].
How the interaction of CSN with CRLs is regulated is
unknown. However, the interaction can clearly be subject
to active regulation as shown by the rapid release of the
CRL4DDB2 complex from CSN upon UV irradiation, and
conversely, the rapid binding of the CRL4CSA complex to
CSN upon UV irradiation (both CRL4DDB2 and CRL4CSA
are involved in aspects of DNA damage repair) [29]. More
generally, substrate binding has been implicated in the
regulation of neddylation and deneddylation. Substrate
binding increases the neddylation levels of human CUL1,
CUL2, CUL3, and CUL4 in vivo [51,110,111].  In vitro
experiments indicate that substrate binding increases ned-
dylation levels by preventing the deneddylation of cullins
by CSN [110]. Substrate binding presumably blocks
deneddylation either by inhibiting the deneddylation of
CRLs that are bound to CSN or by preventing the associa-
tion of CRLs with CSN. In contrast to the in vitro results, in
vivo experiments indicate that substrate binding to CUL1
can increase neddylation levels independently of CSN,
suggesting that substrate binding promotes the neddyla-
tion reaction in cells [111].
Regulation of CRLs by the inhibitor CAND1
TIP120A/CAND1 (cullin-associated and neddylation-dis-
sociated) is an inhibitor that binds to cullin-Rbx com-
plexes that lack both neddylation and adaptors [112-115].
CAND1 is a 120 kDa protein composed of multiple HEAT
repeats. The crystal structure of human CAND1 bound to
a CUL1-Rbx1 complex indicates that CAND1 wraps
around the cullin, with the CAND1 N-terminus bound to
the cullin C-terminus and the CAND1 C-terminus bound
to the cullin N-terminus [116] (Fig. 4). CAND1 binding
blocks both the adaptor binding site and the Nedd8 con-
jugation site.
CAND1 is capable of binding to all cullins in human cells
[112,114]. However, in certain cells, CAND1 preferen-
tially associates with a subset of cullins. In human
HEK293T cells, CAND1 associates primarily with CUL1
[111,115]. CAND1 can also bind to CUL4A and CUL5 in
HEK293T cells, but there is no observed interaction with
CUL2 or CUL3 [112]. In contrast, in human HeLa cells,
CAND1 interacts with CUL1, CUL2, CUL3, and CUL4A
[114]. The reason for these differences (either based on
cell lines or experimental conditions) is not understood.
In C. elegans, CAND1 binds at high level to CUL-2, but
does not have detectable binding to CUL-3 [117,118].
CAND1 binding to cullin-Rbx is incompatible with ned-
dylation. The presence of Nedd8 on the cullin blocks
CAND1 binding, suggesting that CAND1 binds to cullin-
Rbx only after CSN has removed Nedd8 [112,113].
CAND1 can dissociate the adaptor Skp1 from unned-
dylated CUL1 in vitro, suggesting that once Nedd8 has
been removed, CAND1 is capable of stripping off the
adaptor and binding the cullin [112] (Fig. 4).
Counterintuitively, inactivation of CAND1 leads to the
inactivation of SCF complexes in humans and Arabidopsis,
and CUL3 complexes in humans [36,61,113,119-121]. In
the case of human SCFSkp2, the inactivation of CAND1 is
correlated with reduced levels of the SRS Skp2, which is
proposed to result from autoubiquitination [36,113]. In
contrast, the activity of the CRL3Keap1 complex is inhibited
upon CAND1 inactivation even though increased levels of
Keap1 bind to CUL3, and Keap1 interaction with its sub-
strate is increased, suggesting that the presence of CAND1
is required for CRL3Keap1 activity independently of SRS sta-
bilization [61].
It is reasonable to assume that cells do not produce
CAND1 in order to permanently sequester cullin-Rbx
complexes, as this would be energetically wasteful. It is
therefore pertinent to ask how cullin-Rbx is released from
CAND1. There are two potential mechanisms that have
been tested to address CAND1 dissociation, the first is
neddylation, and the second is the binding of additionalCell Division 2008, 3:7 http://www.celldiv.com/content/3/1/7
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Proposed activation cycle for an SCF complex Figure 4
Proposed activation cycle for an SCF complex. Diagram of a proposed SCF activation cycle. The SCF complex can shift 
between an active dimeric complex and a CSN-bound state in which the cullin is deneddylated and the SRS is protected from 
autoubiquitination (top). The mechanisms that regulate SCF interaction with CSN are not fully understood, but substrate bind-
ing may be associated with either releasing SCF from CSN or preventing SCF binding to CSN. When substrate is lacking, SCF 
complexes can either rebind CSN or lose their SRS due to autodegradation. Loss of the SRS (by autoubiquitination or the 
activity of other E3 ligases) allows deneddylation by the CSN complex. The deneddylated adaptor-cullin-Rbx1 complex can 
then either rebind an SRS to reform an SCF complex (horizontal arrow) or undergo sequestration by CAND1 (bottom), in 
which the adaptor is stripped away from cullin-Rbx1 in the process of CAND1 binding. CAND1 is released via an as yet unde-
fined mechanism that involves cullin-Rbx1 binding either to the adaptor (shown) or an adaptor-SRS complex (not shown). The 
adaptor-cullin-Rbx1 complex binds an SRS dimer to form a dimeric SCF complex. Substrate binding promotes cullin neddyla-
tion to allow full activation of the SCF complex. Proteins are labeled as in Figs 1 and 2.
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CRL components. Neddylation was initially shown to dis-
sociate CAND1 based on in vitro experiments with endog-
enous human CUL1 that was bound to antibody after
immunoprecipitation [112]. However, studies using solu-
ble, recombinant CUL1 showed that CAND1 is not disso-
ciated by neddylation and instead completely blocks
access to the neddylation site [116,122]. It should be
noted that these experiments used different sources of
CUL1, endogenous and recombinant (see below).
The second mechanism for CAND1 dissociation is the
binding of CRL components. Two groups obtained some-
what different results for this mechanism. Zheng et al.
reported that CAND1 could be dissociated from endog-
enous CUL1 by the addition of the adaptor Skp1 and ATP
[113]. However, Bornstein et al. indicated that the Skp1-
Skp2 complex (but not Skp1 alone) could dissociate
CAND1 from endogenous CUL1, and that ATP had no
effect on the dissociation [110]. It is currently unclear
whether adaptor-SRS or adaptor alone is involved in the
release of cullin-Rbx. Nevertheless, it is significant that
Bornstein et al. showed that Skp1-Skp2 could dissociate
CAND1 from endogenous CUL1 but not from recom-
binant CUL1 [110]. The finding that endogenous CUL1 is
more easily released from CAND1 implies a role for either
critical post-translationally modification(s) of CUL1 or a
'dissociation factor'.
It has recently been reported that co-inactivation of
murine c-Abl and the related c-Arg tyrosine kinase is asso-
ciated with increased binding between CUL4A and
CAND1 [123]. This suggests that murine c-Abl and c-Arg
either promote the dissociation of CAND1 from CUL4A
or prevent their association. The mechanistic pathway(s)
by which these kinases regulate this interaction has not
been resolved.
Potential crosstalk between CAND1 and CSN
Is there crosstalk between CAND1 and CSN in the regula-
tion of CRLs? In vitro, CAND1 increases the CSN-medi-
ated deneddylation of the SCF complex [124]. In vivo,
inactivation of CAND1 slows the deneddylation rate
(when the neddylation system is inactivated), suggesting
that CAND1 promotes deneddylation [36]. Because
CAND1 has not been observed to physically interact with
CSN, it has been proposed that CAND1 indirectly facili-
tates deneddylation by binding to unneddylated cullins
with high affinity, thereby shifting CSN interactions
towards neddylated cullins [124]. However, it is still pos-
sible that CAND1 plays a more direct role by stripping
unneddylated cullins from the CSN complex. It should be
noted that siRNA depletion of human CAND1 does not
appreciably increase the neddylation levels of CUL1, sug-
gesting that CAND1 is not rate limiting for determining
steady state neddylation levels in human cells [36,113].
A newly discovered CRL interactor, SAP130/SF3b-3, has
the potential to provide feedback links between CSN and
CAND1 [125]. SAP130 is a DDB1-related protein that is a
component of the 17S U2 snRNP particle and the STAGA
and TFTC transcription complexes [126-128]. SAP130
physically associates with CSN, and also binds to com-
plete SCF, CRL2, and CRL4 complexes via direct interac-
tion with the cullins [125]. SAP130 associates almost
exclusively with neddylated cullins. However, inactiva-
tion of CAND1 increases the overall level of CUL2 that
binds to SAP130 (as well as the proportion of unned-
dylated CUL2 that is bound) [125]. Therefore, it appears
that the sequestration of cullins by CAND1 limits their
interaction with SAP130. Currently, the role of SAP130 in
CRL regulation is unclear, and ectopic expression or mod-
erate knockdown of SAP130 does not affect cullin ned-
dylation levels [125]. Nevertheless, SAP130's interaction
with CSN and the regulation of its cullin binding by
CAND1 suggest that SAP130 may provide a functional
link between CSN and CAND1.
CRL activation cycles
CRLs transit through different stages of assembly, seques-
tration, and neddylation. These changes can be consid-
ered an activation cycle, with CRL components switching
from an inactive form (lacking Nedd8 and/or adaptor or
SRS, and potentially sequestered by CAND1) to an active
form (with attached SRS and Nedd8 conjugation). An out-
line of a proposed CRL activation cycle is presented in Fig-
ure 4.
CSN-mediated CRL protection
There appears to be two pathways by which CRLs can
switch between active and inactive forms. One pathway
involves CRL docking with CSN (Fig. 4, top). CSN can
bind to completely assembled CUL1 and CUL4 CRL com-
plexes, based on the observation that all CRL compo-
nents, including SRSs, are found to associate with CSN
[29,95,97,99,101,129,130]. The deneddylation and deu-
biquitination activities of CSN can stabilize SRSs by pre-
venting autoubiquitination [36,103-107]. CSN therefore
keeps CRL complexes in a protected, inactive state. What
regulates CRL binding to CSN is not fully understood.
Substrate binding to SCF complexes is incompatible with
CSN-mediated deneddylation [110], and it is possible
that substrate binding leads to the dissociation of CRL
complexes from CSN or inhibits the association of CRLs
with CSN. Once CRL complexes are released from CSN,
they can become neddylated and fully active. The deple-
tion of substrates may lead to the re-association of CRLs
with CSN, although this has not yet been experimentally
demonstrated.Cell Division 2008, 3:7 http://www.celldiv.com/content/3/1/7
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CAND1-mediated CRL sequestration
The second pathway to modulate CRL activity is initiated
by the degradation of the SRS (Fig. 4). In the absence of
substrate, SRSs can undergo autoubiquitination [56,60].
Additionally, other E3 ligases can induce SRS degradation.
Once the SRS is degraded, the core CRL components can
associate with CSN and undergo deneddylation. CAND1
can presumably dissociate adaptors from the unned-
dylated cullin-Rbx complex in vivo, as CAND1 has been
shown capable of doing so in vitro [112]. The mechanism
by which cullin-Rbx complexes are released from CAND1
sequestration has not yet been resolved. However, once
released, the binding of cullin-Rbx to adaptor and SRS will
reconstitute the CRL complex. The binding of substrate
then induces neddylation and full activity [111].
The purposes of the activation cycle
What is the purpose of the activation cycle for CRLs? There
are three major possibilities. The first purpose appears to
be to allow CRLs to efficiently switch between different
SRSs. SRS degradation frees the core CRL components to
reassemble with new SRSs. A dynamic CRL activation
cycle allows adjustments in the proportions of specific
CRL complexes in order to reflect changes in the cellular
levels of SRSs. It is currently unclear whether CAND1
sequestration is a common aspect of SRS switching or if
CRL components sans-SRS generally bypass this step (Fig.
4). The observation that only certain cullins interact
appreciably with CAND1 in certain mammalian cell lines
suggests that CAND1 sequestration is not a requirement
for SRS switching.
The second purpose of the activation cycle is to stabilize
CRL complexes. Loss of either CSN or CAND1 produces a
loss of CRL activity that is attributable, in large part, to the
autodegradation of SRSs [36,103-107,113]. This suggests
that both CSN and CAND1 are essential to dampen
uncontrolled CRL ubiquitin ligase activity in order to pre-
vent CRLs from "burning out" by autoubiquitination of
the available pool of SRSs.
The third potential purpose is that cycles of neddylation
and deneddylation are directly required for CRL ubiquitin
ligase activity. This model is based largely on studies of
CUL-3 in C. elegans [78]. C. elegans CUL-3 is inactive when
either neddylation or deneddylation pathways are com-
promised, yet combining compromised neddylation and
deneddylation pathways restores CUL-3 function [78].
This suggested that balanced (but slower) cycling between
neddylated and unneddylated states allows CUL-3 activ-
ity, while unchecked neddylation or deneddylation
(which eliminates cycling) is incompatible with CUL-3
activity. However, an alternative interpretation of the
results has been proposed that casts doubt on this model
[37]. CUL-3 dimers created by Nedd8-cullin interaction
require both neddylated and unneddylated CUL3 in equal
proportion [37] (Fig. 2B). Inactivation of either the ned-
dylation or deneddylation pathways by themselves would
produce predominantly unneddylated or neddylated
CUL-3, respectively. In such a situation, the absence of
sufficient levels of both neddylated and unneddylated
CUL-3 would reduce the formation of active Nedd8-cullin
dimers. Therefore, until there is additional evidence, it is
not possible to conclude that neddylation/deneddylation
cycles are inherently required for CRL activity.
Unresolved Questions
There are unresolved questions about multiple aspects of
the global regulation of CRLs. Dimerization has only
recently been recognized as an essential characteristic of
many CRLs. It is not yet known to what extent the differ-
ent dimerization mechanisms are utilized. The SRS-based
dimerization mechanism is well established for SCF com-
plexes but has not been rigorously tested for other cullin-
based CRLs. Conversely, the Nedd8-cullin dimerization
mechanism has so far only been reported for CUL3 CRL
complexes, and the structure has not been fully deter-
mined. Finally, the possibility of monomeric CRL cores
binding to dimeric SRSs has not yet been rigorously
tested.
While the biochemistry of cullin neddylation has been
determined, it is not yet clear how neddylation is regu-
lated in vivo. There is evidence that substrate binding pro-
motes neddylation, yet how substrate binding
mechanistically induces neddylation is not apparent.
There is also evidence that substrate binding inhibits
deneddylation by CSN, but it is unclear if this works by
directly blocking deneddylation or by blocking associa-
tion with CSN. Overall, what regulates the association of
CRLs with CSN and the dissociation of CRLs from CSN is
not well understood.
The functional role of CAND1 in sequestering cullins is
still mysterious. CAND1 is important to prevent SRS aut-
oubiquitination, but so is CSN, and it is unclear why
CAND1 is required in addition to CSN to prevent autou-
biquitination. Additionally, multiple aspects of CAND1
activity are unclear. CAND1 only binds to unneddylated
cullins, but it is not known whether CAND1 binding is
actively coupled to CSN deneddylation, as is suggested by
in vitro experiments. It is also not known how CAND1 is
released from cullin-Rbx in cells. The observation that
endogenous cullins can be released from CAND1 while
recombinant cullins cannot, suggests either that the cullin
must be post-translationally modified or that a 'dissocia-
tion factor' is required to release CAND1. Finally, it is
unclear why CAND1 exhibits preferential binding to par-
ticular classes of cullins in different cell lines and organ-
isms.Cell Division 2008, 3:7 http://www.celldiv.com/content/3/1/7
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The activation cycle is not fully understood. It would be
helpful to know which stages of the cycle are rate limiting
and accumulate CRL components during steady-state con-
ditions. It also remains to be determined whether differ-
ent classes of CRLs employ inherently different activation
cycles. With so many fundamental questions still remain-
ing, it is likely that the study of the regulation of CRL com-
plexes will continue to be an interesting and productive
area of research.
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